BrightOwl Loader Loading


Eager for discovery, I am a highly motivated and dynamic person. Flexible and responsible I am seeking a position in clinical research, which will use organization, writting and communication skills developped during previous working experiences. My experiences in project management and my strong organisational skills permit me to meet targets and deadlines. My multidisciplinar knowledge, my open-mindness and my adaptibility to work independently are assets that I would bring to work. I like new challenge, that is why I am looking to grow in my next role and eventually move into role of greater responsability.


Current Experience

  • Clinical study coordinator (oncology) / CRA Coordinator
    Since November 2014
    Clinical research projects: International Phase I to IV Industrial partners (MSD, Merck, Debiopharm international, Novasco) Areas : Therapeutic pratices (radiotherapy and chemotherapy), oncology (Head and Neck, breast, rectum, brain), Immunology. > Comply with ICH/GCP guidance > Organization > Writting skills : Protocols, CRF, documents related to the studies, visits & annual reports, SOP & regulatory submission > Coordination: Scientitic watches, Comitees & providers management, SAE declaration & databasis reconciliation, management of logistic aspect of studies, Retroplanning, communication & reporting, data analysis, Identification of issues and implementation of contingency plans. > Monitoring : sites and pharmacy initiation, monitoring, closure > Investigation : Selection, Feasability, Inclusion (IVRS, IWRS), eCRF, patient follow-up. > Supervision and CRA formation

Past Experience

  • Clinical study coordinator (cardiology & neurology) / CRA coordinator
    September 2013 --- November 2014
    Clinical research projects : European phase II and III Areas : Therapeutic pratices in neurology and cardiology, Neurology, Cardiology. Coordination activities

  • Teacher of Life science
    January 2012 --- January 2013

  • Immunology & infectious diseases PhD
    September 2009 --- January 2013
    > Technical competencies: Cellular purification, transfection, transformation, infection, biochemical tests, ELISA, western-blot,immuno-staining, immuno-precipitation, PCR, flow cytometry, confocal microscopy, KO mice model. > Writting and conduct of fundamental research projects: Fellowships submissions to governmental and private foundation (Sidaction, National Association on AIDS research, > Financial management > Communication: * Articles: Ben Haij N et al. 2011. Cationic nanoglycolipidic particles as vector and adjuvant for the study of the immunogenicity of SIV Nef protein. International Journal of Pharmaceutics. -- Ben Haij N & al. 2013. HIV-1 Tat protein interaction with TLR4-MD2 receptor complex is required for cytokine production. Retrovirology-- Ben Haij N & al. 2013. HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms -- Ben haij N & al. 2014 HIV-1 Tat induces production of pro-inflammatory cytokines by hDC and monocytes/macrophages through engagement of TLR4-CD14-MD2 complex and activation of NFkB pathways -- Ben Haij N & al. PlosOne 2015. HIV-1 Tat activate both Myd88 and TRIF pathways to induce IL-10 and TNF-a production in human monocytes -- Ben Haij N & al. J. Virology 2016. * Review: In Tech 2011, special edition « HIV-Host interactions book » (editor Thérésa L. Chang). Nova Publisher 2012, « HIV infections ». * Congress: 16th ISHEID 2010, Marseille, France (March 2010) ; Toll Meeting 2011, Riva del Garda, Italy (May 2011) ; 6th IAS 2011, Rome, Italie (July 2011); 6th congress on HIV, Genova, Switherland (March 2012). * Posters : Toll Meeting 2011, Riva del Garda, Italy (May 2011) ; 6th IAS on HIV pathogenesis, treatment and prevention 2011, Rome, Italy (July 2011); 6th congress on HIV, Genova, Switherland (March 2012).

  • Immunology Researcher
    September 2007 --- September 2008

  • Oncology researcher
    January 2007 --- June 2007

  • Immuno-toxicology researcher
    January 2005 --- August 2005


LinkedIn Assessment :
Essais cliniquesImmunologieBonnes pratiques cliniquesClinical researchLife SciencesImmunologyClinical trialsBiotechnologieBiologie molCROBiotechnology


  • Clinical trial investigator MA (medical qualification) = DIU FIEC in clinical research from Medicine University of Laennec, Lyon in 2014
  • Doctor of Philosophy (PhD) in Immunology & infectious disease from Université Paul Sabatier (Toulouse III) in 2013
  • Master's degree in Immunologie et maladies infectieuses from Université Paul Sabatier (Toulouse III) in 2009
  • Master's degree in cellular physiology & physiopathology from Université Paul Sabatier (Toulouse III) in 2008
  • Bachelor's degree in Immunology from Université de Montréal in 2007
  • General Biological & biochemical analysis diploma (DUT) in from Université Blaise Pascal (Clermont-II) - Clermont-Ferrand in 2005

Area / Region

Nice, France


Driving License
  • No